Board meeting scheduled for April 24, 2026 to approve audited standalone financial results for Q4 and FY ended March 31, 2026.
Board will consider recommending final dividend for FY2026, subject to approval at the meeting.
Trading window closure for insider trading compliance remains effective from April 1 to April 26, 2026.